What is the Impact Factor of Adverse Drug Reaction Bulletin?

The journal Adverse Drug Reaction Bulletin is indexed in Web of Science (SCIE, quartile Q1) with official metrics continually updated on ImpaQ.

Is Adverse Drug Reaction Bulletin indexed in Web of Science or Scopus?

Yes, Adverse Drug Reaction Bulletin is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.194 (Q4) and an H-index of 9.

Who publishes Adverse Drug Reaction Bulletin and what is the Article Processing Charge (APC)?

Adverse Drug Reaction Bulletin is published by Wolters Kluwer Health. The estimated Article Processing Charge (APC) is approximately $2,356 USD, subject to institutional waivers and corresponding author affiliations.

WoS SCIE Q1Scopus Q4SCImago #22,309Subscription

Adverse Drug Reaction Bulletin

Identifier (ISSN):0044-6394(Print)/2159-7774(Online)

•

Publisher:Wolters Kluwer Health

Clarivate JCR Index Advisory: Not Indexed in Latest JCR

Official Website Submission Portal Compare

Clarivate Impact Factor (IF 2024)

N/A

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

Impact Factor Trend

Clarivate IF trend for Adverse Drug Reaction Bulletin

WoS Q1

Annual Impact Factor Metric

Current (2025):0

Scopus SJR & RankScopus Q4

0.194

#22,309

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

9 papers with at least that number of citations each

WoS: SCIE / JCRQ1

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessSubscription

4articles/year

0% Gold OA•0% Original Research

Aims & Scope

For over 40 years, Adverse Drug Reaction Bulletin has provided comprehensive coverage in the field of adverse drug reactions. Each issue contains an invited article on a topic of current interest, dealing with specific conditions from drug-induced lung disorders to drug-induced sexual dysfunction, or types of drugs from lipid-lowering agents to poisons antidotes. This bimonthly journal"s articles are timely, succinct and fully referenced

Topics Covered (Recognized by AI)

MedicineBiology83.4%Pharmacology69.9%Internal medicine56.4%Psychology51.1%Psychiatry48.9%Drug41.4%Adverse effect34.8%Intensive care medicine34.2%

Primary Research Areas

Medicine Pharmacology (medical)

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR

No WoS category details available for this journal.

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF—

Articles / Year4

Total Citations0

2025

IF0

Articles / Year7

Total Citations1

2024

IF—

Articles / Year7

Total Citations6

2023

IF—

Articles / Year7

Total Citations10

2022

IF—

Articles / Year7

Total Citations8

Year	Impact Factor	Articles / Year	Total Citations
2026	—	4	0
2025	0	7	1
2024	—	7	6
2023	—	7	10
2022	—	7	8
2021	—	7	8
2020	—	8	19
2019	—	6	9
2018	—	8	13
2017	—	8	13
2016	—	8	44
2015	—	6	6

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #22,309Scopus Q4SCImago Profile

Scopus Coverage:1970, 1973-2025

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q4

0.194

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4

Citations / Doc (2 years)

0.50

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,356 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations9

3-Year Documents18

Citable Documents18

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ4

Pharmacology (medical)Q4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: N/A

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

Updating

Minor Category (Specific Field):

Updating

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Adverse Drug Reaction Bulletin (ISSN: 0044-6394) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wolters Kluwer Health in United States. The periodical holds tracked under Web of Science (SCIE) in quartile Q1, a Scopus SJR indicator of 0.194 (Q4), an H-index of 9.

The journal enforces rigorous peer evaluation with an annual output of approximately 4 scientific articles. In terms of accessibility and author fees, it operates under the Subscription model with an estimated APC of $2,356 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.